Arbutus Biopharma (ABUS) Depreciation & Amortization (CF) (2015 - 2026)
Arbutus Biopharma's Depreciation & Amortization (CF) came in at $11,000 for Q2 2026, unchanged from $11,000 a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Arbutus Biopharma (ABUS) Depreciation & Amortization (CF) (2015 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Arbutus Biopharma reported Depreciation & Amortization (CF) of $44,000, down 95.7% year-over-year; for FY2025, it came in at $400,000, down 71.4% from FY2024.
- Depreciation & Amortization (CF) has declined in each of the last seven years, with a five-year compound annual growth rate of -27.5% (FY2020 to FY2025).
- Going back by year, Depreciation & Amortization (CF) was $1.4 million in FY2024 (-0.3%), $1.4 million in FY2023 (-1.6%), $1.43 million in FY2022 (-20.7%) and $1.8 million in FY2021 (-10.0%).
- The five-year range for quarterly Depreciation & Amortization (CF) is $11,000 (Q2 2025) to $474,000 (Q4 2021).
- The fastest year-over-year change in Depreciation & Amortization (CF) over five years came in Q3 2023 (growth of 7.6%), and the weakest in Q2 2025 (a decline of 96.9%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.96 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 194.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 599.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.93 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.11 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 98.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 1.62 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 56.50 Mn |
| 10 | Arbutus Biopharma | 944.69 Mn | 571.67 Mn | - | 11,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11,000.00 |
| Mar 31, 2026 | 11,000.00 |
| Sep 30, 2025 | 11,000.00 |
| Jun 30, 2025 | 11,000.00 |
| Mar 31, 2025 | 330,000.00 |
| Sep 30, 2024 | 336,000.00 |
| Jun 30, 2024 | 356,000.00 |
| Mar 31, 2024 | 355,000.00 |
| Sep 30, 2023 | 369,000.00 |
| Jun 30, 2023 | 342,000.00 |
| Mar 31, 2023 | 334,000.00 |
| Sep 30, 2022 | 343,000.00 |
| Jun 30, 2022 | 383,000.00 |
| Mar 31, 2022 | 394,000.00 |
| Dec 31, 2021 | 474,000.00 |
| Sep 30, 2021 | 447,000.00 |
| Jun 30, 2021 | 436,000.00 |
| Mar 31, 2021 | 443,000.00 |
| Dec 31, 2020 | 509,000.00 |
| Sep 30, 2020 | 490,000.00 |
API Access
Arbutus Biopharma Depreciation & Amortization (CF) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=ABUS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "depreciation-and-amortization-cf", "ticker": "ABUS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=ABUS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();